A sense of relief best explains the mildly positive reaction to flat profits at Oxford Instruments (OXIG) last year. Acquisitions guaranteed modest top-line growth, but after a strong fourth quarter, management is confidently predicting an organic improvement this year. The outlook for government-funded R&D has improved, too.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis